Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $19.59 USD
Change Today -0.75 / -3.69%
Volume 105.6K
OMED On Other Exchanges
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Laurence A. Lasky Ph.D.

Director and Member of Nominating & Corporate Governance Committee,OncoMed Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 66 board members in 6 different organizations across 11 different industries.

See Board Relationships


Dr. Laurence A. Lasky, also known as Larry, Ph.D., was a Partner of U.S. Venture Partners. Dr. Lasky was a Venture Partner at U.S. Venture Partners. He was responsible for investing in healthcare technologies, specifically focusing on financing and creating world class biopharmaceutical companies the discovery, development, and commercialization of new therapies to treat major unmet medical needs and biotechnology companies providing goods and services to this industry. ...

Read Full Background

Corporate Headquarters*

800 Chesapeake Drive
Redwood City, California 94063

United States

Phone: 650-995-8200
Fax: 650-995-8600

Board Members Memberships*

Director and Member of Nominating & Corporate Governance Committee


PhD 1978
University of California-Los Angeles
BA 1973
University of California-Los Angeles
Post-Doctoral Training 1981
University of California-Los Angeles

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$37,665
Total Calculated Compensation$286,293
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OMED:US $19.59 USD -0.75


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOMED PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at